Logo image of ZONE

CLEANCORE SOLUTIONS INC-CL B (ZONE) Stock Fundamental Analysis

NYSEARCA:ZONE - NYSE Arca - US1844921064 - Common Stock - Currency: USD

1.36  +0.03 (+2.26%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ZONE. ZONE was compared to 128 industry peers in the Machinery industry. ZONE may be in some trouble as it scores bad on both profitability and health. ZONE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ZONE had negative earnings in the past year.
ZONE had a negative operating cash flow in the past year.
ZONE Yearly Net Income VS EBIT VS OCF VS FCFZONE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

The Return On Assets of ZONE (-30.50%) is worse than 85.94% of its industry peers.
ZONE's Return On Equity of -61.07% is on the low side compared to the rest of the industry. ZONE is outperformed by 82.03% of its industry peers.
Industry RankSector Rank
ROA -30.5%
ROE -61.07%
ROIC N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZONE Yearly ROA, ROE, ROICZONE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

With an excellent Gross Margin value of 49.58%, ZONE belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
In the last couple of years the Gross Margin of ZONE has grown nicely.
ZONE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
ZONE Yearly Profit, Operating, Gross MarginsZONE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

3

2. Health

2.1 Basic Checks

ZONE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZONE has more shares outstanding than it did 1 year ago.
ZONE has a better debt/assets ratio than last year.
ZONE Yearly Shares OutstandingZONE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
ZONE Yearly Total Debt VS Total AssetsZONE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

ZONE has an Altman-Z score of 0.05. This is a bad value and indicates that ZONE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ZONE (0.05) is worse than 79.69% of its industry peers.
ZONE has a Debt/Equity ratio of 0.70. This is a neutral value indicating ZONE is somewhat dependend on debt financing.
ZONE has a Debt to Equity ratio of 0.70. This is in the lower half of the industry: ZONE underperforms 67.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 0.05
ROIC/WACCN/A
WACC11.26%
ZONE Yearly LT Debt VS Equity VS FCFZONE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 2.13 indicates that ZONE has no problem at all paying its short term obligations.
ZONE has a Current ratio of 2.13. This is comparable to the rest of the industry: ZONE outperforms 54.69% of its industry peers.
A Quick Ratio of 1.69 indicates that ZONE should not have too much problems paying its short term obligations.
ZONE's Quick ratio of 1.69 is fine compared to the rest of the industry. ZONE outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.69
ZONE Yearly Current Assets VS Current LiabilitesZONE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

ZONE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.11%, which is quite impressive.
ZONE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.26%.
The Revenue has been decreasing by -1.36% on average over the past years.
EPS 1Y (TTM)27.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.2%
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZONE Yearly Revenue VS EstimatesZONE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZONE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZONE Price Earnings VS Forward Price EarningsZONE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZONE Per share dataZONE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZONE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANCORE SOLUTIONS INC-CL B

NYSEARCA:ZONE (5/2/2025, 3:45:00 PM)

1.36

+0.03 (+2.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.14%
Inst Owner Change0%
Ins Owners58.95%
Ins Owner Change1.72%
Market Cap11.38M
AnalystsN/A
Price TargetN/A
Short Float %3.93%
Short Ratio1.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.09
P/FCF N/A
P/OCF N/A
P/B 3.05
P/tB 972.92
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.19
BVpS0.45
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.5%
ROE -61.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.58%
FCFM N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.71%
Cap/Sales 0.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.69
Altman-Z 0.05
F-Score4
WACC11.26%
ROIC/WACCN/A
Cap/Depr(3y)62.75%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-338.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-337.14%
OCF growth 3YN/A
OCF growth 5YN/A